MedTrace Logo

Positive End Expiratory Pressure With A T-piece Resuscitator For Near-Term and Term Infants With Respiratory Distress

NCT01859533 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2013-05-22

No results posted yet for this study

Summary

Evaluating the effect of early application of Continuous positive airway pressure (CPAP) via Neopuff in cases of transient tachypnea of the newborn(TTN) and its role in decreasing the duration and complication of TTN.

Conditions

  • Transient Tachypnea of the Newborn

Interventions

DEVICE

Neopuff

* Group I neonates (Experimental group) includes 30 newborns showing signs of TTN who will receive administration of CPAP (5 cm of H2O) via T- piece (Neopuff; Fisher and Paykel Healthcare, Auckland, New Zealand). * Group II neonates (Control group) includes 30 newborns who will receive nasal prong oxygen treatment; standard care according to Siva Subramanian et al. (2010).

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Rania A. El-Farrash, MD, PhD · Associate Professor of Pediatrics, Department of Pediatrics, Ain Shams University, Cairo, Egypt

  • Amani O. Mahmoud, MD · Professor of Pediatrics, Department of Pediatrics, Ain Shams University, Cairo, Egypt

  • Enas H. Abdul-Hady, M.B.B.Ch · Ministry of Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
2 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-01-31
Completion
2013-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01859533 on ClinicalTrials.gov